Ensign Peak Advisors’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Hold |
118,378
| – | – | ﹤0.01% | 1080 |
|
|
2025
Q1 | $1.19M | Hold |
118,378
| – | – | ﹤0.01% | 1150 |
|
|
2024
Q4 | $1.4M | Hold |
118,378
| – | – | ﹤0.01% | 1117 |
|
|
2024
Q3 | $1.37M | Hold |
118,378
| – | – | ﹤0.01% | 1139 |
|
|
2024
Q2 | $1.25M | Hold |
118,378
| – | – | ﹤0.01% | 1144 |
|
|
2024
Q1 | $1.25M | Sell |
118,378
-731,472
| -86% | -$7.71M | ﹤0.01% | 1173 |
|
|
2023
Q4 | $9.54M | Hold |
849,850
| – | – | 0.02% | 452 |
|
|
2023
Q3 | $9.93M | Buy |
849,850
+738,150
| +661% | +$8.62M | 0.02% | 394 |
|
|
2023
Q2 | $1.13M | Buy |
111,700
+1,450
| +1% | +$14.6K | ﹤0.01% | 1166 |
|
|
2023
Q1 | $814K | Hold |
110,250
| – | – | ﹤0.01% | 1414 |
|
|
2022
Q4 | $881K | Buy |
110,250
+74,650
| +210% | +$596K | ﹤0.01% | 1262 |
|
|
2022
Q3 | $115K | Buy |
+35,600
| New | +$115K | ﹤0.01% | 2055 |
|